MALARIA PREVENTION

This study tests an experimental vaccine called PvCS/Montanide ISA-51 to see if it can safely prevent malaria caused by the P. vivax parasite. 72 healthy adults aged 18-50 will receive three shots of the vaccine or a placebo, then be exposed to infected mosquitoes under medical s…

This study tests a new device called LASER Guardian™ that releases chemicals to keep mosquitoes away from homes. Over two years, 69 villages in western Kenya will use either the LASER device, indoor insecticide spraying, or standard prevention methods. Researchers will check abou…

This early-stage study tests whether giving malaria medication to everyone living with a pregnant woman can help protect her from getting malaria. Researchers will enroll 300 households in Uganda to see if this approach is practical and acceptable. The goal is to find a better wa…

This study tests a new long-acting injection called MMV371 to see if it can safely prevent malaria. About 80 healthy people aged 12 to 50 in Rwanda will get either the study drug or a placebo. Researchers will check for side effects and measure drug levels in the body over 24 wee…